Covid19

Nos collègues cliniciens sont en première ligne pour soigner les patients atteints du Covid 19.

  • Dr. Matthieu Boisson

    MCU-PH, Anesthésie - Réanimation

  • Pr. Claire Dahyot-Fizelier

    PU-PH, chef de service de la Réanimation Neurochirurgicale et Chirurgicale

  • Pr. Olivier Mimoz

    PU-PH, chef de service des Urgences

  • Pr. Blandine Rammaert

    PU-PH, Service des maladies infectieuses

  • Pr. France Roblot

    PU-PH, chef de service des maladies infectieuses

Welcome !

Inserm U1070 “Pharmacology of Antimicrobial Agents”, is a Research Unit affiliated to the University of Poitiers and INSERM. It has been created in 2012 and comprises 20 permanent staff members (clinicians, pharmacists and scientists) and 13 students (PhD and master students). It is located on the University Campus of Poitiers (France). The objective of Inserm U1070 is to develop innovative PK/PD modelling approaches to select the best dosing regimen of antibiotics administered alone or in combination as well as the best route of administration and best formulation, in order to increase antimicrobial efficacy and limit bacterial resistance. Inserm U1070 conducts translational research, from cells culture models to patients, and integrating microbiology, analytical chemistry, drug formulation, and in vivo preclinical experiments.
To date, Inserm U1070 received grants from Region Nouvelle Aquitaine, ANR, PHRC, JPIAMR, IMI and CPER-FEDER and has established collaborations with ANSES and several Universities in France (Paris Sud, Paris Diderot) and abroad (Dublin, Erasmus MC, Upssala, Hambourg, Catholic University of Louvain…), as well as leading pharmaceutical companies.

News



Twitter


  • Follow us on